Dengue Outbreak: Brazil Approves Vaccine Dengvaxia by Sanofi SA
The Philippines’ Food and Drug Administration approved Dengvaxia for the prevention of dengue caused by all four types in individuals between the ages of 9 to 45 who reside in endemic areas. Its main task is to aid in preventing the disease that is caused by four dengue...
Posted On Dec 29 2015